Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

Scancell and Celltech collaborate on antibody therapeutics to Lewis(y/b)

Aug. 11, 2003

GPC Biotech makes progress on various fronts with 1D09C3

Aug. 6, 2003

Grant supports development of cancer vaccines at Epimmune using analogue epitopes

Aug. 1, 2003

Phase II trial indicates promising efficacy for alemtuzumab in MF/SS

July 31, 2003

Anti-gp75 antibodies evaluated as potential therapies for melanoma

July 25, 2003

BMS evaluates the potential of agonist antibodies targeting CD137 for antitumor therapy

July 24, 2003

Further positive results reported from phase Ib trial of Cancer Vac immunotherapy

July 23, 2003

Early completion anticipated for pivotal R-1549 trial

July 21, 2003

MEDI-507 proven effective in a murine model of adult T-cell leukemia

July 15, 2003

MDX-010 combined with tumor vaccines in metastatic melanoma

July 14, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...